| 摘要 |
<p>The invention relates to the field of apoptosis. The invention provides novel therapeutic substances, for example novel therapeutic (non) viral vectors or proteinaceous compounds that contain apoptin in conjunction with cytotoxic agents, especially in those cases when cells are derailed such as cancer-autoimmune-derived cells.</p> |
